NCT06622967

Brief Summary

The CadAI-B (Computer Aided Design Artificial Intelligence-Breast) system is a real-time AI diagnostic tool for breast ultrasound. It integrates with ultrasound devices to detect suspicious lesions, providing size, BI-RADS, and malignancy probability. After installation and user training, the system displays real-time breast conditions and automatically analyzes lesions when a freeze frame is set, showing results in seconds. This study will assess CadAI-B\'s accuracy and reliability by comparing its findings with biopsy results.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 2, 2024

Status Verified

September 1, 2024

Enrollment Period

2 months

First QC Date

September 17, 2024

Last Update Submit

September 30, 2024

Conditions

Keywords

breast neoplasmultrasound

Outcome Measures

Primary Outcomes (1)

  • Lesion and Per-patient Diagnostic Performance

    AUC (Area Under the Curve), Sensitivity, Specificity

    At the end of the trial, up to 6 months

Secondary Outcomes (1)

  • Lesion and Per-patient Detection Performance

    At the end of the trial, up to 6 months

Other Outcomes (1)

  • BeamWorks Usability Evaluation Scale (Score of BeamWorks System Usability Scale (SUS))

    At the end of the trial, up to 6 months

Study Arms (1)

CadAI-B intervention group

EXPERIMENTAL

Participants in this arm will receive the CadAI-B system for the detection of lesions. The AI-based tool will assist healthcare professionals in identifying lesions through enhanced image analysis.

Diagnostic Test: CadAI-B

Interventions

CadAI-BDIAGNOSTIC_TEST

The ultrasound is performed following the usual process. If there are any lesions or areas of concern identified by the patient, a more detailed analysis is conducted on the affected area. When a lesion is confirmed, the examiner verifies the results through the frozen image, while also securing the results displayed on CadAI-B. The examiner uses the analysis from CadAI-B as a reference to make the final BI-RADS classification. Static images and cine clips are captured from the most suspicious areas.

CadAI-B intervention group

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 20 years or older
  • Individuals scheduled to undergo breast ultrasound for diagnostic evaluation
  • Patients whose Ground Truth can be determined through biopsy, surgery, or follow-up

You may not qualify if:

  • Images containing artifacts that may affect the interpretation
  • Presence of breast implants
  • Significant breast trauma or mastitis at the time of the breast ultrasound that could cause distortion in image interpretation
  • History of surgery or chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyungpook National University Chilgok Hospital

Daegu, South Korea

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Jeeyeon Lee, MD, PhD

    Kyungpook National University Chilgok Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 17, 2024

First Posted

October 2, 2024

Study Start

September 15, 2024

Primary Completion

October 31, 2024

Study Completion

December 31, 2024

Last Updated

October 2, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations